Cyprus latest patents query
The latest invention patents collect the data information of Cyprus invention patents from 2000 to 2024, typesetting according to the date of patent publication, including patent number, application date, invention Bibliographic data, abstracts, and specification data of people are convenient for scientific researchers to quickly browse and search for patents.
MOTOR BOAT WITH HYDROFINALS THAT RETRACT BY TUPPLING
UndeterminedCY1125993T1Vertical planeClassical mechanics
Owner:ENATA HLDG FOUNDATION
DETECTION OF DAMPING BASED ON DEFORMATION FIELD OR MAGNETIC FIELD
UndeterminedCY1126690T1Structural engineeringMechanical engineering
Owner:TOKAMAK ENERGY
PEGYLATED LIPOSOMES FOR DELIVERY OF RNA ENCODING AN IMMUNOGEN
UndeterminedCY1125995T1DiseaseLipofectamine
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
METHOD FOR THE PRODUCTION OF BIOFUEL BY CONVERTING A MELTED POLYMERIC MATERIAL MIXED WITH SUPERCRITICAL WATER
UndeterminedCY1126162T1BiofuelEnvironmental engineering
Owner:MURA TECH LTD
A BIN FOR RECYCLABLE WASTE
UndeterminedCY1125702T1Mechanical engineeringIndustrial engineering
Owner:GLOBAL BINS DESIGNS LTD
HUMAN ANTIBODY AGGREGANASSY-TYPE ADAMTS FOR THERAPEUTICS OF AGGREGANASSY-RELATED DISEASES
UndeterminedCY1127228T1DiseaseAntiendomysial antibodies
Owner:GENEFRONTIER CORP
SELECTION AND USE OF MELATONIN-SUPPORTING BACTERIA TO REDUCE INFANT COLISON
UndeterminedCY1125773T1DiseaseLactic acid bacterium
Owner:BIOGAIA AB
TRANSFORMING GROWTH FACTOR BETA-RESPONSIVE POLYPEPTIDES AND METHODS OF USING THEM
UndeterminedCY1126000T1Antigen bindingBinding domain
Owner:RGT UNIV OF CALIFORNIA
2,4,6,7-TETRAHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-5-ONE DERIVATIVES AND RELATED COMPOUNDS AS C5A RECEPTOR MODULATORS FOR THE TREATMENT OF VAGUITIS AND INFLAMMATORY DISEASES
UndeterminedCY1125737T1NeuritisPharmacology
Owner:IDORSIA PHARMACEUTICALS LTD
MASK FOR THE TREATMENT OF DRY EYES
UndeterminedCY1125895T1EyelidElectrical battery
Owner:LABORATOIRES THEA SAS
TRIAZACYCLODODECANESULFONAMIDE ("TCD")-BASED PROTEIN SECRETION INHIBITORS
UndeterminedCY1126160T1DiseasePharmacy medicine
Owner:KEZAR LIFE SCI
PREGABALINE CONTROLLED RELEASE TABLETS, METHOD OF CREATING THEM AND METHOD OF USING THEM
UndeterminedCY1126167T1PregabalinSoftware engineering
Owner:ALVOGEN INC
METHOD FOR PRODUCING AN ELECTRICAL TRANSMISSION CABLE
UndeterminedCY1125688T1Metallic materialsElectric cables
Owner:NV BEKAERT SA
HANDLE MOUNTING CENTER TRANSPORT ADAPTER
UndeterminedCY1126225T1Structural engineeringMechanical engineering
Owner:PLASTICS OF SOUTHEAST EUROPE - ONE MAN LTD
MICE EXPRESSING A LIMITED REPERTORY OF IMMUNOGLOBIN LIGHT CHAINS
UndeterminedCY1126014T1Alpha globulinImmunoglobulin light chain
Owner:REGENERON PHARMACEUTICALS INC
METHOD FOR SHAPING THE EDGE OF CELLULOSE PRODUCTS IN A FORMING MOLD SYSTEM AND FORMING MOLD SYSTEM FOR SHAPING THE EDGE OF CELLULOSE PRODUCTS
UndeterminedCY1125899T1CelluloseFiber
Owner:PULPAC AB
DEVICE FOR PRODUCING IMPACT PULSES OR VIBRATIONS FOR A CONSTRUCTION MACHINE
UndeterminedCY1126272T1Reciprocating motionControl cell
Owner:EURODRILL GMBH
SEPARATION OF POLYMER FROM COMPOSITE STRUCTURES
UndeterminedCY1125843T1Polymer scienceOrganic solvent
Owner:PVC SEPARATION HLDG PTY LTD
METHODS OF TREATING MULTIPLE MYELOMA WITH IMMUNOREGULATORY COMPOUNDS IN COMBINATION WITH ANTIBODIES
UndeterminedCY1125886T1Antiendomysial antibodiesElotuzumab
Owner:CELGENE CORP
MONOCLONAL ANTIBODIES AGAINST CHORUS AND METHODS OF PREPARING AND USING THEM
UndeterminedCY1126226T1AntigenAntigen Binding Fragment
Owner:REDCOAT SOLUTIONS INC
HETEROARYL PDE4 INHIBITORS
UndeterminedCY1125954T1DiseasePDE4 Inhibitors
Owner:TETRA DISCOVERY PARTNERS
MACROCYCLIC COMPOUND AND ITS USES
UndeterminedCY1125745T1FibroblastPharmaceutical medicine
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE
PHYSICALLY AND CHEMICALLY STABLE BY MOUTH GIVINOSTAT
UndeterminedCY2025031I1Mechanical engineeringChemistry
Owner:ΔΙΚΑΙΟΎΧΟΥ
THERAPEUTIC USES OF EMPAGLIFLOZIN
UndeterminedCY1125680T1Oxidative stressEmpagliflozin
Owner:BOEHRINGER INGELHEIM INT GMBH
SYSTEM AND METHOD FOR PRODUCTION AND APPLICATION OF NON-PORTLAND CEMENT-BASED MATERIAL
UndeterminedCY1125951T1SlagPortland cement
Owner:ENTECH CORP
METHODS OF ASSOCIATING GENETIC VARIANTS WITH CLINICAL OUTCOME IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTI-VEGF THERAPY
UndeterminedCY1126278T1Therapy resistantANK2
Owner:REGENERON PHARMACEUTICALS INC
ORAL SOLUTIONS CONTAINING FLUDROCORTIZONE ACETATE
UndeterminedCY1126227T1CortisoneTG - Triglyceride
Owner:LABOMED PHARM CO SA
PHARMACEUTICAL FORMS CONTAINING CORTICOSTEROIDS FOR TOPICAL ADMINISTRATION
UndeterminedCY1125865T1Corticosteroid preparationDicarboxylic acid
Owner:BAUSCH HEALTH IRELAND LTD
NEW ANALOGUES AS REGULATORS OF ANDROGONE RECEPTORS AND GLUCOCORTICOD RECEPTORS
UndeterminedCY1125964T1DiseasePsychosis drug
Owner:ONCOSTELLAE SL
FLUID SYSTEM FOR REAGENT DELIVERY IN A FLOW CELL
UndeterminedCY1125796T1Flow cellLiquid state
Owner:ILLUMINA INC
FOOD SUPPLEMENT, SUITABLE FOR ORAL ADMINISTRATION, CONTAINING LACTOFERRIN, XYLOGLYCAN, PROANTHOCYANIDINS AND SIMETHICONE FOR THE COMMON PREVENTION OF GASTROINTESTINAL AND URINARY TRACT INFECTIONS
UndeterminedCY1125643T1Upper urinary tract infectionDietary supplement
Owner:TSETI IOULIA
N-ACETYLOCYSTEINE FOR USE AS AN ANTIBACTERIAL AGENT
UndeterminedCY1125955T1Stenotrophomonas maltophiliaAntibacterial agent
Owner:ZAMBON SPA
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR AND A BCL-2 INHIBITOR
UndeterminedCY2025030I1DepressantCancer research
Owner:ΔΙΚΑΙΟΎΧΟΥ
METHOD FOR PRODUCING, USING AND RELEASE OF ACTIVATED STEM CELLS
UndeterminedCY1126433T1Wavelength modulationLaser beams
Owner:OVOKAITYS TODD F
USE OF THYROID HORMONE T4 IN HIGH-VOLATILITY THERAPY IN PATIENTS TAKING PROTON PUMP INHIBITORS
UndeterminedCY1127303T1MedicineDepressant
Owner:ALTERGON SA
HUMANIZED T CELL MEDIATED IMMUNE RESPONSES IN NON-HUMAN ANIMALS
UndeterminedCY1126222T1T cellMechanical engineering
Owner:REGENERON PHARMACEUTICALS INC
DOUBLE BASE PLATE FOR TRANSFER OF FORCES TO THE GROUND FOR OLMOS TRANSPORT VEHICLES
UndeterminedCY1125985T1Classical mechanicsMortar
Owner:NEW TECH GLOBAL SYST
PRODUCTS AND COMPOSITIONS
UndeterminedCY1125872T1DiseaseExpression gene
Owner:SILENCE THERAPEUTICS GMBH
PYRIDOSTIGMIN SUSTAINED-RELEASE COMPOSITIONS
UndeterminedCY1126220T1Polymer sciencePyridostigmine
Owner:VIANEX SA
HETEROCYCLIC COMPOUNDS AS IMMUNOMEDULGENTS
UndeterminedCY1125746T1DiseaseImmunomodulating Agent
Owner:INCYTE CORP
SMALL LIPOSOMES FOR DELIVERY OF RNA ENCODING AN IMMUNOGEN
UndeterminedCY1126019T1DiseaseLipofectamine
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
USE OF LAMININ FOR DIFFERENTIATION OF HOLOPHYDRANATE CELLS TOWARDS HEPATOCYTE CELL LINEARITY
UndeterminedCY1125931T1Germ layerLaminin
Owner:INSERM INST NAT DE LA SANTE & DE LA RE
ANTIGENIC PEPTIDES FOR CANCER PREVENTION AND TREATMENT
UndeterminedCY1125761T1Cancer preventionHuman tumor
Owner:ENTEROME
COMBINATION THERAPY WITH CONTROLLED-RELEASE CNP AGONISTS
UndeterminedCY1125957T1Pharmaceutical drugAgonist
Owner:ASCENDIS PHARMA GROWTH DISORDERS AS
METHOD FOR FORMING A MULTILAYER SPECTRAL SEPARATION FILTER FOR PHOTOVOLTAIC AND THERMAL USES AND FILTER AND PRODUCTION FACILITY RELATED TO THE SAID METHOD
UndeterminedCY1126233T1Refractive indexEngineering
Owner:BLUESOLAR FILTERS SL
METHOD AND DEVICE FOR AIR PURIFICATION
UndeterminedCY1126240T1FiltrationAir decontamination
Owner:VAN WEES INNOVATIONS BV
ANTIBODIES AGAINST THE SARS-COV-2 SPIKE GLYCOPROTEIN AND ANTIGEN-BINDING FRAGMENTS
UndeterminedCY1126023T1AntigenAntigen Binding Fragment
Owner:REGENERON PHARMACEUTICALS INC
SOLID FORMS OF TTK INHIBITORS
UndeterminedCY1125988T1DiseasePharmaceutical drug
Owner:UNIV HEALTH NETWORK
COFFEE MACHINE WITH TEMPERATURE ADJUSTMENT AND CONTROL UNIT
UndeterminedCY1126028T1Solenoid valveWater flow
Owner:MOJER LTD
NEW PHTHALAZINONE DERIVATIVES AND METHOD FOR THEIR INDUSTRIAL MANUFACTURE
UndeterminedCY1126251T1Pharmaceutical drugPerylene derivatives
Owner:IDIENCE CO LTD
PROCESS FOR DEHYDRATION OF A HYDROCARBON GAS
UndeterminedCY1125945T1DesiccantProcess engineering
Owner:AXENS SA
CARRIER SYSTEM COMPRISING A CARRIER AND A MOBILE DEVICE FOR TREATING SOIL AND / OR FOR HANDLING FLORA AND FAUNA AND METHOD THEREFOR
UndeterminedCY1126010T1Communication interfaceCommunication unit
Owner:NAITURE GMBH & CO KG
A METHOD FOR THE PRODUCTION OF FIBER-REINFORCED CEMENTITIOUS SUSPENSION USING A MULTI-STAGE CONTINUOUS MIXER
UndeterminedCY1125808T1Fiber suspensionAqueous medium
Owner:UNITED STATES GYPSUM CO
MIGRAINE PREVENTION AND TREATMENT
UndeterminedCY1126224T1Hydroxybutyric acidAcetic acid
Owner:UNIVS KINDERSPITAL BEIDER BASEL
ADMINISTRATION SCHEME OF THYROID HORMONE T4 SOLUTIONS WITH HIGH ORAL ABSORPTION
UndeterminedCY1126777T1Dosing regimenAbsorption rate
Owner:ALTERGON SA
STABILIZED FLUOROELEFIN COMPOSITIONS AND METHODS FOR THE PRODUCTION, STORAGE AND USE THEREOF
UndeterminedCY1125801T1Polymer scienceAlkene
Owner:THE CHEMOURS CO FC LLC
METHOD AND INSTALLATION FOR PROCESSING SUNFLOWER SEED FLOUR
UndeterminedCY1127241T1Mechanical engineeringMechanics
Owner:HIPROSUN HIGH PROTEIN SUNFLOWER EXTRACTION MEAL GMBH
HUMANIZED ANTIBODIES AGAINST PSMA
UndeterminedCY1125792T1AntigenProstate specific membrane
Owner:HEIDELBERG PHARMA RES GMBH
NITRILE-CONTAINING COMPOUNDS USEFUL AS ANTIVIRAL AGENTS FOR THE TREATMENT OF CORONAVIRUS INFECTION
UndeterminedCY1125666T1Viral infectionOrganic chemistry
Owner:PFIZER INC
CONTROLLED CAPACITOR AND METHOD FOR CONTROLLING AND MANUFACTURING SUCH A CAPACITOR
UndeterminedCY1126180T1SupercapacitorDielectric permittivity
Owner:DIGITAL CONCEPTS CO LTD
CAPACITIVE EMBEDDED DUAL INTERFACE METAL CARD
UndeterminedCY1126157T1Mechanical engineeringPhysics
Owner:COMPOSECURE LLC
SMALL LIPOSOMES FOR DELIVERY OF RNA ENCODING AN IMMUNOGEN
UndeterminedCY1125998T1DiseaseLipofectamine
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
DRUG RELEASE SYSTEMS AND METHODS FOR TREATING BLADDER CANCER WITH GEMCITABINE
UndeterminedCY1125667T1OncologyDrug release
Owner:TARIS BIOMEDICAL
AN AQUACULTURE PROCESS FOR THE PRODUCTION OF SALMON EGGS
UndeterminedCY1125641T1SalmoZoology
Owner:BENCHMARK GENETICS ICELAND HF
SUBSTITUTED TRIAZOLOQUINOXALINE DERIVATIVES
UndeterminedCY1125637T1DiseaseGlucocorticoid receptor
Owner:GRUNENTHAL GMBH
NEW HYDROXY ACID DERIVATIVES, METHOD FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UndeterminedCY1125983T1Acid derivativePharmaceutical drug
Owner:VERNALIS (R&D) LTD
ANTI-CANCER FUSION POLYPEPTIDE
UndeterminedCY1125916T1AnticarcinogenCancer cell
Owner:PIERIS PHARMA GMBH
DEVICE FOR MEASURING OPERATING PARAMETERS OF ESPRESSO COFFEE MACHINES
UndeterminedCY1125684T1Espresso coffeeMechanics
Owner:DE VECCHI GIUSEPPE SRL
CHEMICALLY ENCODED AND SPATIALLY LOCATED LIBRARIES SCREENING PLATFORMS
UndeterminedCY1126193T1Protecting groupLibrary
Owner:CITY OF HOPE
DEOXY-CYTIDINE DERIVATIVES FOR USE IN CANCER THERAPY
UndeterminedCY1126221T1Cancer therapyMechanical engineering
Owner:HEMISPHERIAN AS
INNOVATIVE ENZYMES AND CRISPR DNA TARGETING SYSTEMS
UndeterminedCY1126189T1Dna targetingDNA
Owner:ARBOR BIOTECHNOLOGIES INC
MONOHYDRATE CRYSTALLINE COMPLEX OF 1-CYANO-2-(4-CYCLOPROPYL-BENZYL)-4-(BETA-D-GLYCOPYRANOS-1-YL)-BENZENE, AND L-PROLINE IN CRYSTAL WATER (1:1:1), METHODS FOR ITS PREPARATION AND USE AS SGLT INHIBITOR
UndeterminedCY1125817T1PyranoseBenzene
Owner:BOEHRINGER INGELHEIM VETMEDICA GMBH
ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION THAT HAVE ANTICANCER ACTIVITY
UndeterminedCY1125718T1Pharmaceutical drugPharmaceutical Substances
Owner:CANCER RESEARCH TECHNOLOGY LTD
MICROFLUIDIC CHIP-BASED UNIVERSAL COAGULATION TEST
UndeterminedCY1125849T1Anticoagulant AgentAnti coagulation
Owner:PEROSPHERE TECHNOLOGIES INC
COMBINATION OF A MEK INHIBITOR AND A B-RAF INHIBITOR
UndeterminedCY1127091T1MEK inhibitorDepressant
Owner:NOVARTIS AG
COMPOSITIONS AND METHODS FOR TREATING WOUNDS
UndeterminedCY1125774T1Active agentPolyethylene glycol
Owner:ELUCIDERM INC
NEW IRON COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF
UndeterminedCY1126208T1SucroseMedicinal chemistry
Owner:RENIBUS THERAPEUTICS INC
DOSE DETECTION SYSTEM COMPONENT FOR DRUG ADMINISTRATION DEVICE
UndeterminedCY1126286T1Pharmacy medicinePharmaceutical drug
Owner:ELI LILLY & CO
METHOD OF SETTING ACCESS TO A DATA CONNECTION FROM AN ELECTRONIC DEVICE
UndeterminedCY1125714T1Data connectionMaximum duration
Owner:SAINTS GRP SRL
ECOLOGICAL BUILDING WITH AN ORGANIC AGRICULTURAL AQUACULTURE FUNCTION AND AN INTERNAL CIRCULATION TREATMENT FUNCTION
UndeterminedCY1126215T1Environmental resource managementOrganic farming
Owner:SONG ZHIYUAN
ISOXAZOLES AS FXR RECEPTOR AGONISTS
UndeterminedCY1125812T1DiseasePharmacy medicine
Owner:BAR PHARM SARL
COUPLING DEVICE FOR THE STRUCTURAL ASSEMBLY OF STRUCTURES OR OBJECTS
UndeterminedCY1125909T1Mechanical engineeringPhysics
Owner:PACARADA ELVIR
PROCEDURE FOR QUANTIFYING THE TOTAL CONTENT OF SAPONINS IN A SAMPLE, ESPECIALLY IN A COMPLEXED SAMPLE
UndeterminedCY1125913T1Food industryNutrition
Owner:NOR FEED
NIRAPARIB, AMBIRATERON ACETATE AND PREDNISONE FOR PROSTATE CANCER TREATMENT
UndeterminedCY1125675T1GlucocorticoidProstate cancer
Owner:JANSSEN PHARMA NV
ZINC OXIDE CERAMIC VARISTORS
UndeterminedCY1125753T1Oxide ceramicDopant
Owner:RIPD INTELLECTUAL ASSETS LTD
CHAIN TENSIONER WITH CHAIN SWITCH DEVICE
UndeterminedCY1125646T1Chain linkMechanics
Owner:STEVLOS BV
ANIMAL FOOD AND METHOD FOR ITS PREPARATION
UndeterminedCY1125884T1Animal foodAspergillus oryzae
Owner:BOSKEIN NUTRITION LTD
ANTICANCER PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY
UndeterminedCY1126274T1MorpholinePharmaceutical drug
Owner:BERLIN CHEMIE AG
ANTIBODIES AGAINST REGULATORY PROTEIN ALPHA AND METHODS OF USE
UndeterminedCY1126288T1NucleotidePolynucleotide
Owner:ALX ONCOLOGY INC
ANTIBODY-DRUG CONJUGATES AND THEIR USES FOR CANCER THERAPY
UndeterminedCY1125910T1DiseaseAntiendomysial antibodies
Owner:INATHERYS
USE OF A PHARMACEUTICAL CARRIER IN THE PREPARATION OF AN ANTIDIABTIC PHARMACEUTICAL COMPOSITION CONTAINING BERBERINE AND ORYZANOL
UndeterminedCY1126171T1SoftgelDiabrezide
Owner:BEIJING RONGXIANG INST OF REGENERATIVE MEDICINE
COMPOSITION COMPRISING A RIGID (CO)POLYESTER AND A FLEXIBLE (CO)POLYESTER, METHOD FOR PREPARATION AND USE IN GEOTEXTILE AND FOR FISHING DEVICE
UndeterminedCY1126154T1PolyesterBiochemistry
Owner:ICCI SEA
DEVICE WITH ATTACHABILITY TO THE BODY AND METHOD THEREOF
UndeterminedCY1126165T1Human bodyElectro stimulation
Owner:BOREAL TECH & INVESTMENT SL
ONCOLYTIC VIRUS AND METHOD
UndeterminedCY1126294T1Replication competent virusPharmaceutical drug
Owner:AKAMIS BIO LTD
ADHESIVE FIBER PANELS FOR THE CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES
UndeterminedCY1127825T1FiberControl release
Owner:BIOINICIA SL
COMBINATION OF IMETELSTAT AND VENECLAX FOR THE THERAPEUTIC TREATMENT OF ACUTE MYELOGENIC LEUKEMIA
UndeterminedCY1125939T1TelomeraseHematological Tumor
Owner:GERON CORP
METHOD AND SYSTEM FOR PREVENTING BIOLOGICAL POLLUTION ON SURFACES
UndeterminedCY1125803T1
Owner:KONINKLIJKE PHILIPS NV
ENANTI-ROR2 ANTIBODIES, ANTIBODY FRAGMENTS, IMMUNOCONDUCTIONS THEREOF AND USES THEREOF
UndeterminedCY1125639T1Heavy chainAntibody fragments
Owner:BIOATLA LLC
PROVISION FOR THE CONTINUOUS ADMINISTRATION OF A THERAPEUTIC FLUID
UndeterminedCY1125991T1Human bodyFluid infusion
Owner:F HOFFMANN LA ROCHE & CO AG
ELECTRONIC DEVICE WITH FLEXIBLE PROJECTION WINDOW
UndeterminedCY1125971T1AdhesiveDisplay device
Owner:SAMSUNG ELECTRONICS CO LTD
TOPICAL CIPROFLOXACIN COMPOSITIONS
UndeterminedCY1126265T1AntifungalTopical antibacterial
Owner:TAP PHARMA AG
ANTI-N3PGLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
UndeterminedCY2025036I1Antiendomysial antibodiesAmyloid beta
Owner:ΔΙΚΑΙΟΎΧΟΥ
PROJECTOR FOR FIXING FACADE ELEMENTS
UndeterminedCY1126279T1Classical mechanicsCantilever
Owner:EJOT AUSTRIA GMBH & CO KG
METHOD OF FILLING A DISINFECTION DEVICE, ESPECIALLY FOR SANITARY GOODS AND RELATED ITEMS
UndeterminedCY1125965T1BiochemistryCancer research
Owner:BOLTON MANITOBA SPA
ARTICULATED TRANSPORT SYSTEM WITH A SYSTEM FOR CONNECTING AND DISCONNECTING WAGONS
UndeterminedCY1125738T1Transport systemTransit system
Owner:HAYDEN AG
VIROBODY-LIKE DISTRIBUTION PARTICLES FOR SELF-REPLICATING RNA MOLECULES
UndeterminedCY1125727T1DiseaseIn vivo
Owner:GLAXOSMITHKLINE BIOLOGICALS SA
BUPRENORPHINE EXTENDED-RELEASE PHARMACEUTICAL FORMS
UndeterminedCY1125854T1IsobutanolBenzoic acid
Owner:ALAR PHARMA INC
ANTI-MUC16-CD3 AMPHIBIOUS ANTIBODIES AND ANTI-MUC16 DRUG CONJUGATES
UndeterminedCY1126307T1Drug conjugationAntiendomysial antibodies
Owner:REGENERON PHARMACEUTICALS INC
COMPLETE CONTINUOUS ISOLATION OF LIQUID STREAMS FROM ASEPTIC PROCESSING CONTAINERS
UndeterminedCY1125711T1Therapeutic proteinEnvironmental engineering
Owner:GENZYME CORP
FILTHY FIELD INHIBITORS
UndeterminedCY1125706T1DiseaseBromodomain
Owner:CELGENE QUANTICEL RESEARCH INC
SECONDARY ANALOGUES OF EFITOXIN, THEIR DERIVATIVES AND USES
UndeterminedCY1125619T1Pharmaceutical drugPharmaceutical medicine
Owner:GABA THERAPEUTICS INC
CNP PRODRUGS WITH CARRIER LINKAGE TO THE RING DEGREE
UndeterminedCY1125710T1DiseasePharmaceutical drug
Owner:ASCENDIS PHARMA GROWTH DISORDERS AS
SYSTEM FOR PREVENTING BIOLOGICAL POLLUTION AT A LEVEL BASED ON UV-C RADIATION
UndeterminedCY1125732T1Luminescent materialMaterials science
Owner:KONINKLIJKE PHILIPS NV
PHARMACEUTICAL PREPARATIONS CONTAINING HIGHLY VOLATILE SILICONES
UndeterminedCY1125908T1BULK ACTIVE INGREDIENTSilicone fluid
Owner:EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENY TARSASAG
PESTICIDE PREPARATIONS THAT HAVE A NATURAL MODE OF ACTION
UndeterminedCY1125868T1Active agentMicrobiology
Owner:ICB PHARMA
COMPOSITE WOOD CONSTRUCTION METHOD
UndeterminedCY1125924T1Polymer sciencePlant fibre
Owner:HANDELSONDERNEMING WE HA
RTI COMPOUNDS WITH LOW PEAK TO BASE RATIO
UndeterminedCY1125958T1Pharmaceutical drugPharmaceutical Substances
Owner:ASCENDIS PHARMA BONE DISEASES AS
METHOD FOR DISCHARGING AN ELECTROCHEMICAL GENERATOR
UndeterminedCY1127281T1ElectrochemistryOrganic chemistry
Owner:COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
PHARMACOTROPHIC OPHTHALMIC COMPOSITION FOR THE TREATMENT OF AMPHIBLYSTEROID PATHOLOGIES HAVING A NEOVASCULAR COMPONENT
UndeterminedCY1125904T1OPHTHALMOLOGICALSBlood vessel
Owner:LABORATOIRES THEA SAS
RIP1 INHIBITOR COMPOUNDS AND METHODS FOR THEIR PREPARATION AND USE
UndeterminedCY1126293T1DiseasePharmaceutical drug
Owner:RIGEL PHARMACEUTICALS INC
3-((((((2S,5R)-2-KAPBAMOYL-7-OXO-1,6-DIAZADICYCLO[3.2.1]OCTAN-6-YL)OXY)SULFONYL)OXY)-2,2-DIMETHYLPROPANOIC DERIVATIVES AND RELATED COMPOUNDS AS ORALLY ADMINISTERED PRODRUGS OF BETA-LACTAMASE INHIBITORS FOR THE TREATMENT OF BACTERIAL INFECTIONS
UndeterminedCY1126211T1Propanoic acidAcid derivative
Owner:ARIXA PHARMACEUTICALS INC
EMBRYONIC GENOMIC ANALYSIS FROM A MATERNAL BIOLOGICAL SAMPLE
UndeterminedCY1125818T1MedicineEmbryo
Owner:THE CHINESE UNIVERSITY OF HONG KONG
DRY POWDER PREPARATION CONTAINING A CORTICOSTEROID AND A BETA-ADRENERGENT FOR INHALATION
UndeterminedCY1125742T1AdrenergicInhalation
Owner:CHIESI FARMACEUTICI SPA
CO2 DISPLACEMENT UNIT FOR CONVERTING SOLID WASTE INTO SYNTHESIS GAS
UndeterminedCY1125987T1SyngasEnvironmental engineering
Owner:RWE GENERATION NL BV
MACROCYCLES AS MODULATORS OF TRANSMEMBRANE CONDUCTANCE REGULATOR IN CYSTIC FIBROSUS, PHARMACEUTICAL COMPOSITIONS THEREOF, THEIR USE IN THE TREATMENT OF CYSTIC FIBROSUS, AND METHOD FOR MANUFACTURING THEM
UndeterminedCY2025034I1FibrosisPharmaceutical drug
Owner:ΔΙΚΑΙΟΎΧΟΥ
METHOD FOR DETERMINING PML RISK
UndeterminedCY1125851T1Progressive multifocal leukoencephalopathyIntensive care medicine
Owner:BIOGEN MA INC
CRYSTALLINE SALT OF 4-(4-(1-ISOPROPYL-7-OXO-1,4,6,7- TETRAHYDRO-SPIRO[INDAZOLE-5,4'-PIPERIDINE]-1'- CARBONYL)-6-METHOXYPYRIDIN-2-YL)BENZOIC ACID WITH 2-AMINO-2-(HYDROXYMETHYL)PRO-PAN-1,3- DIOL
UndeterminedCY1125994T1Benzoic acidDisease
Owner:PFIZER INC
USE OF VEGF ANTAGONIST FOR THE THERAPEUTIC TREATMENT OF ANAGOGENETIC OCULAR DISORDERS
UndeterminedCY1125653T1Diabetes retinopathyVascular endothelial growth factor
Owner:REGENERON PHARMACEUTICALS INC
SOFT GELATIN CAPSULES CONTAINING HYDROXYPROPYL-BETA-CYCLODEXTRINE WITH HIGH STABILITY
UndeterminedCY1127144T1Polymer scienceCyclodextrin
Owner:ALTERGON SA
METHOD AND DEVICE FOR MARKING SUBBLOCK TRANSFORMATION INFORMATION
UndeterminedCY1128252T1Block transformOrganic chemistry
Owner:ALIBABA GROUP HOLDING LTD
MITOCHONDRIA-TARGETING PEPTIDES
UndeterminedCY1125943T1Cardiac ischaemiaTarget peptide
Owner:STEALTH BIOTHERAPEUTICS INC
NEW PHARMACEUTICAL COMPOSITION FOR DRUG DISTRIBUTION
UndeterminedCY1125670T1CyclodextrinPharmacometrics
Owner:OREXO AB